Literature DB >> 26743090

Progressive Multifocal Leukoencephalopathy in Primary Immune Deficiencies: Stat1 Gain of Function and Review of the Literature.

Christa S Zerbe1, Beatriz E Marciano1, Rohit K Katial2, Carah B Santos2, Nick Adamo1, Amy P Hsu1, Mary E Hanks1, Dirk N Darnell1, Martha M Quezado3, Cathleen Frein4, Lisa A Barnhart1, Victoria L Anderson1, Gulbu Uzel1, Alexandra F Freeman1, Andrea Lisco1, Avindra Nath5, Eugene O Major6, Elizabeth P Sampaio1, Steven M Holland1.   

Abstract

BACKGROUND: Progressive multifocal leukoencephalopathy (PML) is a rare, severe, otherwise fatal viral infection of the white matter of the brain caused by the polyomavirus JC virus, which typically occurs only in immunocompromised patients. One patient with dominant gain-of-function (GOF) mutation in signal transducer and activator of transcription 1 (STAT1) with chronic mucocutaneous candidiasis and PML was reported previously. We aim to identify the molecular defect in 3 patients with PML and to review the literature on PML in primary immune defects (PIDs).
METHODS: STAT1 was sequenced in 3 patients with PML. U3C cell lines were transfected with STAT1 and assays to search for STAT1 phosphorylation, transcriptional response, and target gene expression were performed.
RESULTS: We identified 3 new unrelated cases of PML in patients with GOF STAT1 mutations, including the novel STAT1 mutation, L400Q. These STAT1 mutations caused delayed STAT1 dephosphorylation and enhanced interferon-gamma-driven responses. In our review of the literature regarding PML in primary immune deficiencies we found 26 cases, only 54% of which were molecularly characterized, the remainder being syndromically diagnosed only.
CONCLUSIONS: The occurrence of PML in 4 cases of STAT1 GOF suggests that STAT1 plays a critical role in the control of JC virus in the central nervous system. Published by Oxford University Press for the Infectious Diseases Society of America 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  PID; PML; STAT1 gain of function; primary immunodeficiency; progressive multifocal leukoencephalopathy

Mesh:

Substances:

Year:  2016        PMID: 26743090      PMCID: PMC4803104          DOI: 10.1093/cid/civ1220

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  42 in total

1.  Visual loss due to progressive multifocal leukoencephalopathy in a congenital immunodeficiency disorder.

Authors:  S M Downes; G C Black; N Hyman; M Simmonds; J Morris; C Barton
Journal:  Arch Ophthalmol       Date:  2001-09

2.  Progressive multifocal leukoencephalopathy in a patient with X-linked agammaglobulinemia.

Authors:  Takahide Teramoto; Hideo Kaneko; Michinori Funato; Hirofumi Sawa; Kazuo Nagashima; Yoshinobu Hirose; Naomi Kondo
Journal:  Scand J Infect Dis       Date:  2003

3.  Chronic mucocutaneous candidiasis caused by a gain-of-function mutation in the STAT1 DNA-binding domain.

Authors:  Shunichiro Takezaki; Masafumi Yamada; Masahiko Kato; Myoung-Ja Park; Kenichi Maruyama; Yasuhiro Yamazaki; Natsuko Chida; Osamu Ohara; Ichiro Kobayashi; Tadashi Ariga
Journal:  J Immunol       Date:  2012-06-22       Impact factor: 5.422

4.  JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosis.

Authors:  Spyridon Chalkias; Xin Dang; Evelyn Bord; Marion C Stein; R Philip Kinkel; Jacob A Sloane; Maureen Donnelly; Carolina Ionete; Maria K Houtchens; Guy J Buckle; Stephanie Batson; Igor J Koralnik
Journal:  Ann Neurol       Date:  2014-06-10       Impact factor: 10.422

5.  Progressive multifocal leukoencephalopathy: clinical and radiographic features.

Authors:  L B Krupp; R B Lipton; M L Swerdlow; N E Leeds; J Llena
Journal:  Ann Neurol       Date:  1985-04       Impact factor: 10.422

6.  Genetic analysis of JC virus and BK virus from a patient with progressive multifocal leukoencephalopathy with hyper IgM syndrome.

Authors:  Gui Ping Han; Katsutoshi Miura; Yoshihiro Ide; Yoshihiro Tsutsui
Journal:  J Med Virol       Date:  2005-07       Impact factor: 2.327

Review 7.  Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

Authors:  Michael W Ferenczy; Leslie J Marshall; Christian D S Nelson; Walter J Atwood; Avindra Nath; Kamel Khalili; Eugene O Major
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

8.  Unusual MRI and pathologic findings of progressive multifocal leukoencephalopathy complicating adult Wiskott-Aldrich syndrome.

Authors:  T Matsushima; K Nakamura; T Oka; N Tachikawa; T Sata; S Murayama; N Nukina; I Kanazawa
Journal:  Neurology       Date:  1997-01       Impact factor: 9.910

9.  Association between simian virus 40 DNA and lymphoma in the United kingdom.

Authors:  Jane MacKenzie; Katherine S Wilson; Jacqueline Perry; Alice Gallagher; Ruth F Jarrett
Journal:  J Natl Cancer Inst       Date:  2003-07-02       Impact factor: 13.506

Review 10.  Progressive multifocal leukoencephalopathy and idiopathic CD4 lymphocytopenia.

Authors:  Manuel Delgado-Alvarado; María José Sedano; Vicente González-Quintanilla; Enrique Marco de Lucas; José Miguel Polo; José Berciano
Journal:  J Neurol Sci       Date:  2013-03-05       Impact factor: 3.181

View more
  24 in total

1.  Clinical challenges in the management of patients with B cell immunodeficiencies.

Authors:  J P Hodkinson; H Chapel
Journal:  Clin Exp Immunol       Date:  2017-06       Impact factor: 4.330

2.  Reducing persistent polyomavirus infection increases functionality of virus-specific memory CD8 T cells.

Authors:  Qingsong Qin; Matthew Lauver; Saumya Maru; Eugene Lin; Aron E Lukacher
Journal:  Virology       Date:  2017-01-05       Impact factor: 3.616

Review 3.  Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary Immunodeficiencies.

Authors:  Kathleen E Sullivan; Hamid Bassiri; Ahmed A Bousfiha; Beatriz T Costa-Carvalho; Alexandra F Freeman; David Hagin; Yu L Lau; Michail S Lionakis; Ileana Moreira; Jorge A Pinto; M Isabel de Moraes-Pinto; Amit Rawat; Shereen M Reda; Saul Oswaldo Lugo Reyes; Mikko Seppänen; Mimi L K Tang
Journal:  J Clin Immunol       Date:  2017-08-07       Impact factor: 8.317

4.  Progressive Multifocal Leukoencephalopathy in Primary Immunodeficiencies.

Authors:  Jérôme Hadjadj; Aurélien Guffroy; Christophe Delavaud; Guillaume Taieb; Isabelle Meyts; Anne Fresard; Nathalie Streichenberger; Anne-Sophie L'Honneur; Flore Rozenberg; Maud D'Aveni; Claire Aguilar; Jérémie Rosain; Capucine Picard; Nizar Mahlaoui; Marc Lecuit; Olivier Hermine; Olivier Lortholary; Felipe Suarez
Journal:  J Clin Immunol       Date:  2018-12-14       Impact factor: 8.317

Review 5.  Progressive multi-focal leucoencephalopathy - driven from rarity to clinical mainstream by iatrogenic immunodeficiency.

Authors:  S A Misbah
Journal:  Clin Exp Immunol       Date:  2017-03-27       Impact factor: 4.330

6.  Alanine-scanning mutagenesis of human signal transducer and activator of transcription 1 to estimate loss- or gain-of-function variants.

Authors:  Reiko Kagawa; Ryoji Fujiki; Miyuki Tsumura; Sonoko Sakata; Shiho Nishimura; Yuval Itan; Xiao-Fei Kong; Zenichiro Kato; Hidenori Ohnishi; Osamu Hirata; Satoshi Saito; Maiko Ikeda; Jamila El Baghdadi; Aziz Bousfiha; Kaori Fujiwara; Matias Oleastro; Judith Yancoski; Laura Perez; Silvia Danielian; Fatima Ailal; Hidetoshi Takada; Toshiro Hara; Anne Puel; Stéphanie Boisson-Dupuis; Jacinta Bustamante; Jean-Laurent Casanova; Osamu Ohara; Satoshi Okada; Masao Kobayashi
Journal:  J Allergy Clin Immunol       Date:  2016-12-20       Impact factor: 10.793

Review 7.  Human STAT1 Gain-of-Function Heterozygous Mutations: Chronic Mucocutaneous Candidiasis and Type I Interferonopathy.

Authors:  Satoshi Okada; Takaki Asano; Kunihiko Moriya; Stephanie Boisson-Dupuis; Masao Kobayashi; Jean-Laurent Casanova; Anne Puel
Journal:  J Clin Immunol       Date:  2020-08-27       Impact factor: 8.317

8.  Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype.

Authors:  Julie Toubiana; Satoshi Okada; Julia Hiller; Matias Oleastro; Macarena Lagos Gomez; Juan Carlos Aldave Becerra; Marie Ouachée-Chardin; Fanny Fouyssac; Katta Mohan Girisha; Amos Etzioni; Joris Van Montfrans; Yildiz Camcioglu; Leigh Ann Kerns; Bernd Belohradsky; Stéphane Blanche; Aziz Bousfiha; Carlos Rodriguez-Gallego; Isabelle Meyts; Kai Kisand; Janine Reichenbach; Ellen D Renner; Sergio Rosenzweig; Bodo Grimbacher; Frank L van de Veerdonk; Claudia Traidl-Hoffmann; Capucine Picard; Laszlo Marodi; Tomohiro Morio; Masao Kobayashi; Desa Lilic; Joshua D Milner; Steven Holland; Jean-Laurent Casanova; Anne Puel
Journal:  Blood       Date:  2016-04-25       Impact factor: 22.113

9.  STAT1 gain-of-function heterozygous cell models reveal diverse interferon-signature gene transcriptional responses.

Authors:  Ori Scott; Kyle Lindsay; Steven Erwood; Antonio Mollica; Chaim M Roifman; Ronald D Cohn; Evgueni A Ivakine
Journal:  NPJ Genom Med       Date:  2021-05-14       Impact factor: 8.617

Review 10.  Lessons learned from the study of human inborn errors of innate immunity.

Authors:  Giorgia Bucciol; Leen Moens; Barbara Bosch; Xavier Bossuyt; Jean-Laurent Casanova; Anne Puel; Isabelle Meyts
Journal:  J Allergy Clin Immunol       Date:  2018-08-01       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.